Cardene, Cardene Sr, Nicardipine (nicardipine) is a small molecule pharmaceutical. Nicardipine was first approved as Cardene on 1988-12-21. It is used to treat hypertension, stable angina, and variant angina pectoris in the USA. It is known to target adenosine receptor A3 and potassium voltage-gated channel subfamily A member 4. Cardene iv's patents are valid until 2027-12-26 (FDA).
|Trade Name||Cardene, Cardene In Dextrose, Cardene Sr, Nicardipine|
|Indication||hypertension, stable angina, variant angina pectoris|
|Drug Class||Phenylpyridine vasodilators (nifedipine type)|